The Latest Breaking News from FDA

The cigarette is the only legal consumer product that – when used as intended – causes the premature death of half of long-term users.

Alternate monkeypox treatment caught in regulatory delays

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Here's a roundup of top developments in the biotech space over the last 24 hours:

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

The stock market has witnessed a rough ride amid macroeconomic headwinds this year. Despite the GDP decline for two consecutive quarters, economists believe the economy is far from recession. Here are five fundamentally solid value stocks AstroNova (ALOT), Bristol-Myers Squibb (BMY), Bluegreen Vacations (BVH), GSK (GSK), and Honda Motor (HMC),…

A woman has playfully shamed her dog who would rather skip dinner time than work for his meal - she is now giving away his dog puzzle bowl in hope 'somebody else's dog is smarter than hers'

Here's a roundup of top developments in the biotech space over the last 24 hours:

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

The Food and Drug Administration reportedly has a new strategy for rolling out new booster shots that should bring needed clarity to COVID vaccination in the U.S. Going forward, most Americans will get the same advice about when to get their next shots.